Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04504669
Title First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications

Advanced Solid Tumor

cervical cancer

lung small cell carcinoma

head and neck squamous cell carcinoma

clear cell renal cell carcinoma

triple-receptor negative breast cancer

melanoma

lung non-small cell carcinoma

stomach cancer

Therapies

AZD8701 + Durvalumab

AZD8701

Age Groups: adult | senior
Covered Countries USA | FRA | ESP | CAN


No variant requirements are available.